EV/EBITDA
-0.32
-0.02-6.67%
106 min ago
Summary
- As of March 13, 2025, PRLD EV/EBITDA is -0.32, with a fall of -0.02 (-6.67%) during the most recent trading day.
- Over the past year, PRLD EV/EBITDA has increased by +1.34 (+80.72%).
- PRLD EV/EBITDA is now -6.67% below its all-time high of -0.30.
Performance
PRLD EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PRLD EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -6.7% | +4.8% | +5.5% |
| 1 m1 month | +20.0% | -21.2% | -23.5% |
| 3 m3 months | +17.9% | -19.2% | -21.4% |
| 6 m6 months | +82.4% | -82.9% | -85.6% |
| ytdytd | +37.3% | -38.3% | -41.5% |
| 1 y1 year | +80.7% | -79.9% | -83.1% |
| 5 y5 years | - | - | - |
PRLD EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -6.7% | -0.45 | +28.9% | |
| 3 m | 3-month | -0.30 | -6.7% | -0.58 | +44.8% |
| 6 m | 6-month | -0.30 | -6.7% | -1.82 | +82.4% |
| 1 y | 1-year | -0.30 | -6.7% | -2.43 | +86.8% |
| 3 y | 3-year | -0.30 | -6.7% | -3.49 | +90.8% |
| 5 y | 5-year | -0.30 | -6.7% | -74.73 | +99.6% |
| alltime | all time | -0.30 | -6.7% | -74.73 | +99.6% |
Prelude Therapeutics Incorporated EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.32(-37.3%) |
| 2024 | -0.51(-70.3%) |
| 2023 | -1.72(-18.9%) |
| Date | Value |
|---|---|
| 2022 | -2.12(-57.5%) |
| 2021 | -4.99(-90.0%) |
| 2020 | -49.96 |
FAQ
- What is Prelude Therapeutics Incorporated EV/EBITDA?
- What is the all time high EV/EBITDA for Prelude Therapeutics Incorporated?
- What is PRLD EV/EBITDA year-to-date change?
- What is Prelude Therapeutics Incorporated EV/EBITDA year-on-year change?
What is Prelude Therapeutics Incorporated EV/EBITDA?
The current EV/EBITDA of PRLD is -0.32
What is the all time high EV/EBITDA for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high EV/EBITDA is -0.30
What is PRLD EV/EBITDA year-to-date change?
Prelude Therapeutics Incorporated EV/EBITDA has changed by +0.19 (+37.25%) since the beginning of the year
What is Prelude Therapeutics Incorporated EV/EBITDA year-on-year change?
Over the past year, PRLD EV/EBITDA has changed by +1.34 (+80.72%)